A new layered oxypnictide (Fe 2 P 2 )(Sr 4 Sc 2 O 6 ) have been synthesized by solid-state reaction. This material has an alternating layer stacking structure of anti-fluorite Fe 2 P 2 and perovskite-based Sr 4 Sc 2 O 6 oxide layers. Space group of the material is P4/nmm and lattice constants a and c are 4.016 Å and 15.543 Å, respectively. The interlayer Fe-Fe distance corresponding to the c-axis length is the longest ever reported in the iron-based oxypnictide systems. In both magnetization and resistivity measurements, the present compound exhibited superconductivity below 17 K, which is much higher than that of LaFePO and the highest in arsenic-free iron-based oxypnictide systems under ambient pressure.
Various kinds of N-substituted valiolamine derivatives, including compounds 23a, 24a, and 34a, which are structurally analogous to the key pseudodisaccharides (25a and 26a) of naturally occurring oligosaccharide alpha-D-glucosidase inhibitors, have been synthesized and estimated by the measure of inhibitory activity against porcine sucrase and maltase. The N-substituted valiolamine derivatives evaluated in this study have been found to be more potent than the corresponding N-substituted valienamine derivatives as well as the parent valiolamine. It is noteworthy that even simple N-substituted valiolamine derivatives such as N-[2-hydroxy-1-(hydroxymethyl)ethyl]-, N-[(1R,2R)-2-hydroxycyclohexyl]-, and N-[(R)-(-)-beta-hydroxyphenethyl]valiolamine (6, 8a, and 9a) have the stronger alpha-D-glucosidase inhibitory activity against porcine intestinal maltase and sucrase than naturally occurring oligosaccharide alpha-D-glucosidase inhibitors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.